Once-daily dosed gentamicin is more nephrotoxic than once-daily dosed tobramycin in clinically infected patients

Authors :: Erik M. van Maarseveen
Marie-Christine van Buul-Gast
Cees Neef
Luc Gelinck
Rahat A. Abdoellakhan
Daniel J. Touw
RS: CAPHRI School for Public Health and Primary Care
MUMC+: DA CDL Algemeen (9)
RS: CAPHRI - Clinical epidemiology
RS: CARIM - R3 - Vascular biology
Nanomedicine & Drug Targeting
Biopharmaceuticals, Discovery, Design and Delivery (BDDD)
Groningen Research Institute for Asthma and COPD (GRIAC)
Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE)
Medicinal Chemistry and Bioanalysis (MCB)
Source :: Journal of Antimicrobial Chemotherapy, 69(9), 2581-2583. Oxford University Press, Journal of Antimicrobial Chemotherapy, 69(9):dku175, 2581-2583. Oxford University Press
Publication Year :: 2014
Publisher :: Oxford University Press (OUP), 2014.

Subjects :: Male
glomerulus filtration rate
ODD
creatinine blood level
Pharmacology
intensive care unit
Cohort Studies
chemistry.chemical_compound
antibiotic therapy
Tobramycin
Pharmacology (medical)
randomized controlled trial (topic)
Aged, 80 and over
drug monitoring
nephrotoxicity
informed consent
creatinine
Acute kidney injury
Acute Kidney Injury
Middle Aged
Anti-Bacterial Agents
Infectious Diseases
risk factor
endocarditis
Female
Gentamicin
hospital infection
dosage schedule comparison
medicine.drug
Adult
Microbiology (medical)
letter
tobramycin
gentamicin
Nephrotoxicity
kidney proximal tubule
Antibiotic therapy
medicine
Humans
human
Aged
Retrospective Studies
drug accumulation
aminoglycosides
Creatinine
nonhuman
treatment duration
business.industry
bacterial infection
medicine.disease
Drug accumulation
drug indication
hospital admission
chemistry
Gentamicins
Once daily
business

Tools